JENNIFER STROPE: Open Payments
NPI 1720750771 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 23 payments from 9 companies in 2025. Trend: 2023 $415 · 2024 $706 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $162 |
| Lundbeck LLC | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, Wegovy, REXULTI, AIRSUPRA, SHINGRIX, Rybelsus, GEMTESA, Veozah.
Industry payments across TN — which companies pay providers there.
